Protein detail
ANXA2
Annexin A2 (Annexin II) (Annexin-2) (Calpactin I heavy chain) (Calpactin-1 heavy chain) (Chromobindin-8) (Lipocortin II) (Placental anticoagulant protein IV) (PAP-IV) (Protein I) (p36)
Entry name ANXA2 | UniProt ID | EVMP confidence score 0.50 |
Supporting publications (n) 5 | Transmembrane count | Protein classification Cancer-related genesDisease related genesFDA approved drug targetsPlasma proteinsPredicted intracellular proteinsPredicted secreted proteinsTransporters |
EVMP confidence score
Annotation confidence score; open for threshold definitions.
Extremely high >= 0.85High >= 0.70Medium >= 0.55Low >= 0.40Basic Information11
Protein Names
Annexin A2 (Annexin II) (Annexin-2) (Calpactin I heavy chain) (Calpactin-1 heavy chain) (Chromobindin-8) (Lipocortin II) (Placental anticoagulant protein IV) (PAP-IV) (Protein I) (p36)
Protein Class (7)
Cancer-related genesDisease related genesFDA approved drug targetsPlasma proteinsPredicted intracellular proteinsPredicted secreted proteinsTransporters
Protein Function (6)
- Predicted intracellular proteins
- Cancer-related genes:Candidate cancer biomarkers
- Predicted secreted proteins
- Transporters:Transporter channels and pores
- Disease related genes
- FDA approved drug targets:Small molecule drugs
Ensembl
Entrez Gene Symbol
Gene Synonym (5)
ANX2ANX2L4CAL1HLIP2LPC2D
Gene Description
Annexin A2
Chromosome
15
Position
60347134-60402883
Supporting publications (n)
5
EVMP confidence score
0.50
Fluorescence & Localization4
Tissue SpecificbrainCell SpecificBergmann gliaSingle-Nuclei Brain Specificoligodendrocyte
Function & Pathway7
Protein Function (6)
- Predicted intracellular proteins
- Cancer-related genes:Candidate cancer biomarkers
- Predicted secreted proteins
- Transporters:Transporter channels and pores
- Disease related genes
- FDA approved drug targets:Small molecule drugs
Cellular Component (33)
- GO:0001533 cornified envelope
- GO:0005576 extracellular region
- GO:0005604 basement membrane
- GO:0005615 extracellular space
- GO:0005634 nucleus
- GO:0005737 cytoplasm
- GO:0005765 lysosomal membrane
- GO:0005768 endosome
- GO:0005769 early endosome
- GO:0005811 lipid droplet
Page 1 of 4
Molecular Function (14)
- GO:0001786 phosphatidylserine binding
- GO:0002020 protease binding
- GO:0003723 RNA binding
- GO:0004867 serine-type endopeptidase inhibitor activity
- GO:0005509 calcium ion binding
- GO:0005515 protein binding
- GO:0005544 calcium-dependent phospholipid binding
- GO:0005546 phosphatidylinositol-4,5-bisphosphate binding
- GO:0008092 cytoskeletal protein binding
- GO:0019834 phospholipase A2 inhibitor activity
Page 1 of 2
Biological Process (3)
Reactome (17)
- R-hsa-9855142 cellular responses to mechanical stimuli
- R-hsa-8953897 cellular responses to stimuli
- R-hsa-1280215 cytokine signaling in immune system
- R-hsa-9734767 developmental cell lineages
- R-hsa-9820448 developmental cell lineages of the exocrine pancreas
- R-hsa-9925563 developmental lineage of pancreatic ductal cells
- R-hsa-75205 dissolution of fibrin clot
- R-hsa-8950505 gene and protein expression by jak stat signaling after interleukin 12 stimulation
- R-hsa-109582 hemostasis
- R-hsa-168249 innate immune system
Page 1 of 2
Mediation Categories (5)
Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediationImmune mediationMetabolism mediation
Relations & Evidence82
Enzyme-Mediated Modification (28)
28 records.
| Substrate Gene Symbol | Enzyme Gene Symbol | Enzyme UniProt ID | Residue Type | Residue Offset | Modification | Database | References |
|---|---|---|---|---|---|---|---|
| ANXA2 | PRKCB | P05771 | S | 20 | phosphorylation | MIMPHPRDHPRD_MIMPKEA | KEA:8898866HPRD:8898866HPRD:20068231 |
| ANXA2 | PRKCB | P05771 | S | 26 | phosphorylation | PhosphoSitePhosphoSite_ProtMapperProtMapper | |
| ANXA2 | PRKCB | P05771 | S | 44 | phosphorylation | MIMPHPRD_MIMPphosphoELM_MIMPPhosphoSite_MIMP | |
| ANXA2 | YES1 | P07947 | Y | 24 | phosphorylation | PhosphoSite | |
| ANXA2 | IGF1R | P08069 | Y | 24 | phosphorylation | Sparser_ProtMapperPhosphoSitePhosphoSite_ProtMapperProtMapper | ProtMapper:27821486 |
| ANXA2 | IGF1R | P08069 | Y | 333 | phosphorylation | RLIMS-P_ProtMapperSparser_ProtMapperProtMapper | ProtMapper:27821486 |
| ANXA2 | SCYL2 | Q6P3W7 | S | 22 | phosphorylation | PhosphoNetworks | |
| ANXA2 | SCYL2 | Q6P3W7 | S | 127 | phosphorylation | PhosphoNetworks | |
| ANXA2 | PRKCZ | Q05513 | S | 184 | phosphorylation | PhosphoNetworks | |
| ANXA2 | BMX | P51813 | Y | 275 | phosphorylation | PhosphoNetworks |
Ligand-Receptor Signaling (33)
33 records.
| Category | Parent | Database | Transmitter | Receiver | Secreted | Plasma Membrane (Transmembrane) | Plasma Membrane (Peripheral) |
|---|---|---|---|---|---|---|---|
| intracellular | intracellular | UniProt_location | No | No | Yes | No | No |
| intracellular | intracellular | OmniPath | No | No | Yes | No | No |
| cell_surface_ligand | cell_surface_ligand | connectomeDB2020 | Yes | No | Yes | No | No |
| cell_surface_ligand | cell_surface_ligand | OmniPath | Yes | No | Yes | No | No |
| cell_adhesion | cell_adhesion | Cellinker | Yes | Yes | Yes | No | No |
| adhesion | adhesion | OmniPath | Yes | Yes | Yes | No | No |
| cell_adhesion | cell_adhesion | OmniPath | Yes | Yes | Yes | No | No |
| plasma_membrane | plasma_membrane | Cellinker | No | No | Yes | No | No |
| plasma_membrane | plasma_membrane | OmniPath | No | No | Yes | No | No |
| secreted | secreted | UniProt_keyword | No | No | Yes | No | No |
Regulatory Interaction Network (7)
7 records.
Protein Complex Composition (13)
13 records.
| Component Name | Component Gene Symbols | Component UniProt ID | Stoichiometry | Database | Database IDs | References |
|---|---|---|---|---|---|---|
| ANXA2-PCSK9 complex | ANXA2PCSK9 | P07355Q8NBP7 | 1:1 | ComplexPortal | 1879945814755292228486401476072124808179 | |
| S100A10-annexin 2 complex | ANXA2S100A10 | P07355P60903 | 2:2 | KEGG-MEDICUSComplexPortalCompleathu.MAP2hu.MAP | Compleat:HC736PDB:1a4pintact:EBI-12560506PDB:1bt6 | 176380091217515115350136312607998365891473066611999733147552922294058398862971880797118577571191709269970451266015592236192106685 |
| SMARCA3 - Annexin A2 - S100-A10 complex | ANXA2HLTFS100A10 | P07355P60903Q14527 | 2:2:2 | ComplexPortal | intact:EBI-12560849PDB:4hrgPDB:1bt6PDB:4hrhPDB:1a4pPDB:4hre | 988629711917092147552923126079 |
| TRPV5-S100A10-annexin 2 complex | ANXA2S100A10TRPV5TRPV6 | P07355P60903Q9H1D0Q9NQA5 | 1:1:1:1 | Compleat | Compleat:HC1536 | 12660155 |
| ANXA2TP53 | P04637P07355 | 1:1 | PDB | PDB:7nmi | ||
| ANXA2 | P07355 | 2 | PDB | PDB:7zvxPDB:6t58PDB:5lq0PDB:5lq2PDB:1xjlPDB:2hyw | ||
| ANXA2CTSBS100A10 | P07355P07858P60903 | 1:1:1 | CompleatCFinder | Compleat:HC6581 | ||
| ANXA2S100A4 | P07355P26447 | 2:2 | PDB | PDB:5lpu | ||
| ANXA2PTEN | P07355P60484 | 2:2 | PDB | PDB:7pc7 | ||
| ANXA2S100A10TMTC3 | P07355P60903Q6ZXV5 | 0:0:0 | hu.MAP |
Page 1 of 2Next
Isolation & Detection Technology (1)
1 record.
| EV Isolation Method | Detection Method | Number of References | References |
|---|---|---|---|
| Polymer Precipitation | Western blotting | 1 | 38731868 |
Sequence, Structure & Domains14
Sequences
Length
339
Mass
38,604
Sequence
MSTVHEILCKLSLEGDHSTPPSAYGSVKAYTNFDAERDALNIETAIKTKGVDEVTIVNILTNRSNAQRQDIAFAYQRRTKKELASALKSALSGHLETVILGLLKTPAQYDASELKASMKGLGTDEDSLIEIICSRTNQELQEINRVYKEMYKTDLEKDIISDTSGDFRKLMVALAKGRRAEDGSVIDYELIDQDARDLYDAGVKRKGTDVPKWISIMTERSVPHLQKVFDRYKSYSPYDMLESIRKEVKGDLENAFLNLVQCIQNKPLYFADRLYDSMKGKGTRDKVLIRIMVSRSEVDMLKIRSEFKRKYGKSLYYYIQQDTKGDYQKALLYLCGGDD
Alternative Products
Event=Alternative splicing; Named isoforms=2; Name=1; IsoId=P07355-1; Sequence=Displayed; Name=2; IsoId=P07355-2; Sequence=VSP_038091
Alternative Sequence
1; M -> MGRQLAGCGDAGKKASFKM (in isoform 2)
3D Structural Models
Turn
24..27; 201..204; 233..235; 296..298
Helix
4..12; 35..47; 53..60; 65..79; 83..90; 93..103; 106..117; 125..134; 137..151; 155..161; 165..175; 188..200; 210..219; 222..232; 240..247; 250..264; 266..278; 285..295; 300..311; 315..322; 325..335
Beta Strand
48..50; 120..122; 205..207; 236..238; 279..282
3D Structure
X-ray crystallography (40)
Domain & Motif Annotations
Repeat
33..104; Annexin 1; 105..176; Annexin 2; 189..261; Annexin 3; 265..336; Annexin 4
Domain (CC)
A pair of annexin repeats may form one binding site for calcium and phospholipid.
Region
2..24; S100A10-binding site
Protein Families
Annexin family
Sequence Similarities
Belongs to the annexin family.
Clinical Relevance7
Disease Involvement (2)
Cancer-related genesFDA approved drug targets
Drug Targets (3)
FDA approved drug targetsLiterature-reported targetClinical trial target
Drugs (12)
Interaction Protein (4)
ENSG00000076242ENSG00000132646ENSG00000146648ENSG00000197747
Interaction Count
4
Interaction Dataset
intact_biogrid
Supporting Publications5
| PMID | Title | Abstract |
|---|---|---|
| 22708494 | Multiple roles of annexin A2 in post-transcriptional regulation of gene expression. | Finally, the association of AnxA2 with endosomes and exosomes suggests a role in co-ordinated transport of mRNA and vesicles, i.e. |
| 27574537 | Extracellular vesicles released from cells exposed to reactive oxygen species increase annexin A2 expression and survival of target cells exposed to the same conditions. | No abstract available |
| 28867585 | Protein phosphorylation and its role in the regulation of Annexin A2 function. | The presence of AnxA2 in cancer cell-derived exosomes, as well as the potential regulation of exosomal AnxA2 by phosphorylation or other PTMs, are topics of great interest. |
| 31992335 | Serum exosomal-annexin A2 is associated with African-American triple-negative breast cancer and promotes angiogenesis. | Our previous studies have demonstrated annexin A2 (AnxA2) association with exosomes which promotes angiogenesis and metastasis. |
| 36612209 | Combination of Small Extracellular Vesicle-Derived Annexin A2 Protein and mRNA as a Potential Predictive Biomarker for Chemotherapy Responsiveness in Aggressive Triple-Negative Breast Cancer. | No abstract available |